Podnos Yale (CIK 1891104) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-16). Recent activity: Buy TOI (17,974 shares), Sell TOI (17,974 shares), Buy TOI (5,478 shares), Sell TOI (5,478 shares), Sell TOI (23,451 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-16 | Oncology Institute, Inc. (TOI) | Chief Medical Officer | Buy | 17,974 | $33,611 |
| 2026-07-16 | Oncology Institute, Inc. (TOI) | Chief Medical Officer | Sell | 17,974 | $115,555 |
| 2026-07-16 | Oncology Institute, Inc. (TOI) | Chief Medical Officer | Buy | 5,478 | $10,956 |
| 2026-07-16 | Oncology Institute, Inc. (TOI) | Chief Medical Officer | Sell | 5,478 | $34,785 |
| 2026-06-09 | Oncology Institute, Inc. (TOI) | Chief Medical Officer | Sell | 23,451 | $126,166 |
| 2026-05-22 | Oncology Institute, Inc. (TOI) | Chief Medical Officer | Sell | 1,805 | $8,068 |
| 2026-04-01 | Oncology Institute, Inc. (TOI) | Chief Medical Officer | Buy | 66,446 | $0 |
| 2026-04-01 | Oncology Institute, Inc. (TOI) | Chief Medical Officer | Sell | 16,173 | $49,651 |
| 2026-03-18 | Oncology Institute, Inc. (TOI) | Chief Medical Officer | Sell | 3,420 | $12,278 |
| 2025-11-19 | Oncology Institute, Inc. (TOI) | Chief Medical Officer | Buy | 2,086 | $0 |
| 2025-11-14 | Oncology Institute, Inc. (TOI) | Chief Medical Officer | Buy | 306 | $0 |
| 2025-11-14 | Oncology Institute, Inc. (TOI) | Chief Medical Officer | Buy | 1,202 | $0 |
| 2025-05-22 | Oncology Institute, Inc. (TOI) | Chief Medical Officer | Sell | 1,801 | $4,827 |
来源：SEC Form 4 申报文件 · 截至 2026-07-16